|
CBWD6 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.568500E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.856940E-03 |
| Normal-vs-Stage2 |
8.418600E-03 |
| Normal-vs-Stage3 |
6.46439999973936E-07 |
| Normal-vs-Stage4 |
3.603300E-04 |
| Stage1-vs-Stage2 |
9.112600E-01 |
| Stage1-vs-Stage3 |
3.55219999970124E-07 |
| Stage1-vs-Stage4 |
1.160610E-01 |
| Stage2-vs-Stage3 |
4.776400E-03 |
| Stage2-vs-Stage4 |
2.139000E-01 |
| Stage3-vs-Stage4 |
2.268800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.620300E-04 |
| Normal-vs-AfricanAmerican |
1.811900E-02 |
| Normal-vs-Asian |
1.85750999999179E-05 |
| Caucasian-vs-AfricanAmerican |
8.503000E-01 |
| Caucasian-vs-Asian |
4.329900E-02 |
| AfricanAmerican-vs-Asian |
3.268800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.781000E-04 |
| Normal-vs-Female |
2.954600E-04 |
| Male-vs-Female |
9.235800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.115700E-03 |
| Normal-vs-Age(41-60Yrs) |
1.159650E-04 |
| Normal-vs-Age(61-80Yrs) |
4.823900E-04 |
| Normal-vs-Age(81-100Yrs) |
4.24049999999676E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.514200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.317000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.939900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.792400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.418750E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.334200E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.395100E-03 |
| Classical-VS-Follicular |
2.632400E-01 |
| Classical-VS-Other |
8.413400E-01 |
| Classical-VS-Normal |
4.010300E-04 |
| Tall-VS-Follicular |
1.024580E-03 |
| Tall-VS-Other |
4.391200E-01 |
| Tall-VS-Normal |
1.0563000000241E-06 |
| Follicular-VS-Other |
6.089200E-01 |
| Follicular-VS-Normal |
5.300000E-03 |
| Other-VS-Normal |
1.233970E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.975100E-04 |
| Normal-vs-N1 |
1.478200E-03 |
| N0-vs-N1 |
8.002400E-01 |
|
|
